Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
Objective To compare the efficacy, safety, and cost effectiveness of direct acting oral
anticoagulants (DOACs) for patients with atrial fibrillation. Design Systematic review …
anticoagulants (DOACs) for patients with atrial fibrillation. Design Systematic review …
Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis
BACKGROUND: Atrial fibrillation (AF) is a common cardiac arrhythmia that increases the risk
of thromboembolic events. Anticoagulation therapy to prevent AF-related stroke has been …
of thromboembolic events. Anticoagulation therapy to prevent AF-related stroke has been …
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
Y Vinogradova, C Coupland, T Hill, J Hippisley-Cox - bmj, 2018 - bmj.com
Objective To investigate the associations between direct oral anticoagulants (DOACs) and
risks of bleeding, ischaemic stroke, venous thromboembolism, and all cause mortality …
risks of bleeding, ischaemic stroke, venous thromboembolism, and all cause mortality …
The economic burden of stroke care in England, Wales and Northern Ireland: Using a national stroke register to estimate and report patient-level health economic …
XM Xu, E Vestesson, L Paley, A Desikan… - European stroke …, 2018 - journals.sagepub.com
Introduction Stroke registries are used in many settings to measure stroke treatment and
outcomes, but rarely include data on health economic outcomes. We aimed to extend the …
outcomes, but rarely include data on health economic outcomes. We aimed to extend the …
[HTML][HTML] Increased serum exosomal miR-134 expression in the acute ischemic stroke patients
J Zhou, L Chen, B Chen, S Huang, C Zeng, H Wu… - BMC neurology, 2018 - Springer
Background The exosomal miRNAs have been emerged as biomarkers and therapeutic
targets for various diseases, however, the function of exosomal miRNAs in stroke remains …
targets for various diseases, however, the function of exosomal miRNAs in stroke remains …
[HTML][HTML] Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis
RCP Makam, DC Hoaglin, DD McManus, V Wang… - PloS one, 2018 - journals.plos.org
Background Direct oral anticoagulants (DOACs) have emerged as promising alternatives to
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
[HTML][HTML] Post-operative atrial fibrillation: current treatments and etiologies for a persistent surgical complication
LA Lopes, DK Agrawal - Journal of surgery and research, 2022 - ncbi.nlm.nih.gov
Post-operative atrial fibrillation (POAF) is a persistent and serious surgical complication that
occur in 20-55% of cardiac surgery cases. POAF may lead to adverse health outcomes such …
occur in 20-55% of cardiac surgery cases. POAF may lead to adverse health outcomes such …
Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study
Objective To determine the safety of direct oral anticoagulant (DOAC) use compared with
warfarin use for the treatment of venous thromboembolism. Design Retrospective matched …
warfarin use for the treatment of venous thromboembolism. Design Retrospective matched …
Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic …
Objective To systematically compare the effect of direct oral anticoagulants and low
molecular weight heparin for thromboprophylaxis on the benefits and harms to patients …
molecular weight heparin for thromboprophylaxis on the benefits and harms to patients …
[HTML][HTML] Medicare part D prescribing for direct oral anticoagulants in the United States: cost, use and the “rubber effect”
PD Ziakas, IS Kourbeti, LS Poulou… - PLoS …, 2018 - journals.plos.org
Introduction Direct oral anticoagulants (DOAC) have gained an increased share over
warfarin for prevention and treatment of thromboembolic disease. We studied DOAC …
warfarin for prevention and treatment of thromboembolic disease. We studied DOAC …